Management of Hematologic Adverse Events Associated With Immune Checkpoint Inhibitors

Immune checkpoint inhibitors target suppressor receptors, including cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), and programmed cell death ligand 1 (PD-L1). The activated T cells are not antigen specific; therefore, the blockade of the immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Barbara Barnes, Zawislak, Carolyn, Wong, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163252/
https://www.ncbi.nlm.nih.gov/pubmed/34123476
http://dx.doi.org/10.6004/jadpro.2021.12.4.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163252/
https://www.ncbi.nlm.nih.gov/pubmed/34123476
http://dx.doi.org/10.6004/jadpro.2021.12.4.4

Ejemplares similares